Most Clicked StoriesMore >


Study shows dual fatality risk of high/low HDL cholesterol levels

PCNA SmartBrief | Aug 25, 2016

Both high and low HDL cholesterol levels have been linked to early death risk in a new study, which found a "U-shape" relationship between high-density lipoprotein cholesterol and mortality. The findings "support the notion that there may be a range of HDL-C values where HDL-C may have a helpful effect, beyond which higher HDL-C may not be beneficial and may be associated with untoward outcomes," researchers said. FoodNavigator (08/18)


Heart group says sedentary time increases mortality, health risks

PCNA SmartBrief | Aug 18, 2016

Analysis ties exercise to lower risk of heart disease, diabetes, stroke

PCNA SmartBrief | Aug 11, 2016

2016 Fall Learning Series

PCNA SmartBrief | Aug 04, 2016

PCSK9 inhibitor drugs reduce LDL cholesterol, analysis finds

PCNA SmartBrief | Aug 25, 2016

Study: MetS scores increase from premenopause to menopause

PCNA SmartBrief | Aug 18, 2016

Group releases added sugar intake standards for children

PCNA SmartBrief | Aug 25, 2016

Sleep apnea, resistant hypertension tied to higher heart risks

PCNA SmartBrief | Aug 04, 2016

Study suggests reason for switching anticoagulants

PCNA SmartBrief | Aug 11, 2016

Obesity is strong risk factor for heart failure, study finds

PCNA SmartBrief | Aug 25, 2016


Find PCNA SmartBrief Issues by Date:



PCNA News More >


CE Spotlight -- Race and Ethnicity: Impact on Heart Disease

PCNA SmartBrief | Aug 25, 2016

Call for abstracts -- 2017 Annual Symposium on Cardiovascular Nursing

PCNA SmartBrief | Aug 18, 2016

2016 Fall Learning Series

PCNA SmartBrief | Aug 04, 2016




Sign up for PCNA SmartBrief



Designed specifically for preventive cardiovascular nurses, PCNA SmartBrief is a FREE, weekly e-mail newsletter. By providing the latest need-to-know industry news and information, PCNA SmartBrief saves you time and keeps you smart. Sign up today to receive PCNA SmartBrief. Learn more

Recent Poll view more polls


Share your experience prescribing PCSK9 inhibitors

Chart.